Mytide therapeutics partners with agilent to collaborate on automation solutions for mytide's next-generation manufacturing platform

Boston--(business wire)--mytide therapeutics, a company transforming peptide manufacturing with predictive analytics and machine learning, has partnered with agilent, a global leader in life science, diagnostic and applied chemical markets. the two companies will collaborate on robust, scalable and reliable automation solutions for mytide's biofab2 platform, a technology suite that combines chemistry, robotics and machine learning to advance and accelerate peptide and peptide conjugate manufact
A Ratings Summary
A Quant Ranking